Sign Up to like & get
recommendations!
0
Published in 2019 at "Human pathology"
DOI: 10.1016/j.humpath.2019.05.010
Abstract: We recently experienced cases of pancreatobiliary-type intraductal papillary mucinous neoplasms (PB-IPMNs) with imaging features resembling pancreatic ductal adenocarcinomas (PDACs), and histological appearance of purely pancreatobiliary morphology and highly distorted papillary growth, which led to the…
read more here.
Keywords:
papillary mucinous;
pdacs;
intraductal papillary;
type ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Translational Oncology"
DOI: 10.1016/j.tranon.2019.03.006
Abstract: The bidirectional interaction between pancreatic cancer (PanCa) and diabetes has been confirmed by epidemiological studies, but until now, the underlying molecular mechanisms for this connection is not fully understood yet. Here, we analyzed the clinical…
read more here.
Keywords:
pdac patients;
pdacs;
somatic mutation;
immune related ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Modern Pathology"
DOI: 10.1038/s41379-021-00902-x
Abstract: The literature is highly conflicted on what percentage of pancreatic ductal adenocarcinomas (PDACs) arise in association with intraductal papillary mucinous neoplasms (IPMNs). Some studies have claimed that even small (Sendai-negative) IPMNs frequently lead to PDAC.…
read more here.
Keywords:
pseudo ipmns;
pdacs;
frequency;
pathology ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Gastroenterology"
DOI: 10.1053/j.gastro.2018.03.039
Abstract: BACKGROUND & AIMS The ARID1A gene encodes a protein that is part of the large adenosine triphosphate (ATP)-dependent chromatin remodeling complex SWI/SNF and is frequently mutated in human pancreatic ductal adenocarcinomas (PDACs). We investigated the…
read more here.
Keywords:
ptf1a cre;
cre krasg12d;
pdacs;
pancreatic ductal ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.20833
Abstract: Pancreatic ductal adenocarcinomas (PDACs) are highly aggressive malignancies, associated with poor clinical prognosis and limited therapeutic options. Oncogenic KRAS mutations are found in over 90% of PDACs, playing a central role in tumor progression. Global…
read more here.
Keywords:
pdac cell;
pdacs;
cell lines;
kinase ... See more keywords